Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)
The purpose of this study is to evaluate the relationship between cancer pain and risk of depression among cancer patients.
|Study Design:||Observational Model: Case Control
Time Perspective: Retrospective
|Official Title:||DPRESS Study. Case-control Study in Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients|
- Beck Depression Inventory [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Visual scales analog (EVAs) [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Number of patients with cancer pain. [ Time Frame: 3 months ] [ Designated as safety issue: No ]
|Study Start Date:||November 2007|
|Study Completion Date:||March 2008|
|Primary Completion Date:||March 2008 (Final data collection date for primary outcome measure)|
Visual analogue scales (EVAs) This scale measures the pain intensity.
Other: Visual analogue scales (EVAs)
This scale measures the pain intensity.
This is a retrospective observational and case-control multicenter study. The main objective of this study is determine the degree of association between cancer pain and depression by impact assessment of adequate control of pain associated with cancer risk depression in patients attending the Oncology Unit. The assessment of pain intensity will be performed by using visual analogue scales (EVAs) and verbal descriptive scales, as an observational study, not limit or modify the use of any drug. The patients included in this study have a medical history of cancer pain and mild depression (Beck = 8). The controls are patients with history of cancer pain and mild or absent depression (Beck = 7). n/a
Please refer to this study by its ClinicalTrials.gov identifier: NCT01402830
|Study Director:||Janssen-Cilag S.A. (formerly Janssen Sp) Clinical Trial||Janssen-Cilag, S.A.|